Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

denosumab Injection [Xgeva]

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
BACKGROUND Osteonecrosis of the jaw is a very delicate side effect of Denosumab. The aim of this retrospective study was to… Expand
  • table 1
  • table 2
Is this relevant?
Review
2017
Review
2017
BackgroundTraditional methods for assessing prescriber knowledge can take several years to deliver results. This study was… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
2016
2016
OBJECTIVE Denosumab, a monoclonal antibody, is a relatively new antiresorptive agent that has recently shown a serious adverse… Expand
  • table 3
Is this relevant?
Review
2013
Review
2013
Background: Skeletal-related events (SREs) occur in 80% of patients with advanced breast cancer (BC) and bone metastases. SREs… Expand
Is this relevant?
2012
2012
— Knochenmetastasen sind eine zentrale Ursache für Morbidität und Mortalität beim fortgeschrittenen Prostatakarzinom. Auch hier… Expand
Is this relevant?
2012
2012
— Knochenmetastasen sind eine zentrale Ursache für Morbidität und Mortalität beim fortgeschrittenen Prostatakarzinom. Auch hier… Expand
Is this relevant?
2012
2012
— Knochenmetastasen sind eine zentrale Ursache für Morbidität und Mortalität beim fortgeschrittenen Prostatakarzinom. Auch hier… Expand
Is this relevant?